Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents

Neurointerventional report

Randall C. Edgell, Dileep R Yavagal, Doniel Drazin, Raul Olivera, Alan S. Boulos

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Vertebral artery origin stenosis is a known cause of stroke that is treatable with angioplasty and stenting. Previous studies have demonstrated that this technique is safe but is limited by high rates of in-stent stenosis. Anti-proliferative drug-eluting stents are an alternative for reducing in-stent stenosis at the vertebral artery origin. Methods This retrospective study included five consecutive patients treated with anti-proliferative drug-eluting stents. The patients' demographics, indications for treatment, procedural technique, and clinical and radiographic follow-up are presented along with a review of the literature. Results No peri-procedural complications occurred. One patient had a transient ischemic attack (TIA) during the follow-up period. No patients had hemodynamically significant (>50%) in-stent stenosis at follow-up. Among the 287 cases reported in the literature, there were two strokes (.7%), four TIAs (1.4%), and no procedurally related deaths. Among patients undergoing angiographic follow-up, 26% were found to have >50% in-stent stenosis. Conclusions Anti-proliferative drug-eluting stents hold promise for reducing in-stent stenosis at the vertebral artery origin.

Original languageEnglish
Pages (from-to)175-179
Number of pages5
JournalJournal of Neuroimaging
Volume20
Issue number2
DOIs
StatePublished - Apr 1 2010

Fingerprint

Vertebrobasilar Insufficiency
Drug-Eluting Stents
Stents
Pathologic Constriction
Stroke
Therapeutics
Transient Ischemic Attack
Angioplasty
Retrospective Studies
Demography

Keywords

  • Drug-eluting
  • Stenosis
  • Stent
  • Stroke
  • Vertebral artery origin

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents : Neurointerventional report. / Edgell, Randall C.; Yavagal, Dileep R; Drazin, Doniel; Olivera, Raul; Boulos, Alan S.

In: Journal of Neuroimaging, Vol. 20, No. 2, 01.04.2010, p. 175-179.

Research output: Contribution to journalArticle

Edgell, Randall C. ; Yavagal, Dileep R ; Drazin, Doniel ; Olivera, Raul ; Boulos, Alan S. / Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents : Neurointerventional report. In: Journal of Neuroimaging. 2010 ; Vol. 20, No. 2. pp. 175-179.
@article{650ccc1ac48544f2bceb5d1e03c776a3,
title = "Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents: Neurointerventional report",
abstract = "Background Vertebral artery origin stenosis is a known cause of stroke that is treatable with angioplasty and stenting. Previous studies have demonstrated that this technique is safe but is limited by high rates of in-stent stenosis. Anti-proliferative drug-eluting stents are an alternative for reducing in-stent stenosis at the vertebral artery origin. Methods This retrospective study included five consecutive patients treated with anti-proliferative drug-eluting stents. The patients' demographics, indications for treatment, procedural technique, and clinical and radiographic follow-up are presented along with a review of the literature. Results No peri-procedural complications occurred. One patient had a transient ischemic attack (TIA) during the follow-up period. No patients had hemodynamically significant (>50{\%}) in-stent stenosis at follow-up. Among the 287 cases reported in the literature, there were two strokes (.7{\%}), four TIAs (1.4{\%}), and no procedurally related deaths. Among patients undergoing angiographic follow-up, 26{\%} were found to have >50{\%} in-stent stenosis. Conclusions Anti-proliferative drug-eluting stents hold promise for reducing in-stent stenosis at the vertebral artery origin.",
keywords = "Drug-eluting, Stenosis, Stent, Stroke, Vertebral artery origin",
author = "Edgell, {Randall C.} and Yavagal, {Dileep R} and Doniel Drazin and Raul Olivera and Boulos, {Alan S.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1111/j.1552-6569.2008.00330.x",
language = "English",
volume = "20",
pages = "175--179",
journal = "Journal of Neuroimaging",
issn = "1051-2284",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents

T2 - Neurointerventional report

AU - Edgell, Randall C.

AU - Yavagal, Dileep R

AU - Drazin, Doniel

AU - Olivera, Raul

AU - Boulos, Alan S.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Background Vertebral artery origin stenosis is a known cause of stroke that is treatable with angioplasty and stenting. Previous studies have demonstrated that this technique is safe but is limited by high rates of in-stent stenosis. Anti-proliferative drug-eluting stents are an alternative for reducing in-stent stenosis at the vertebral artery origin. Methods This retrospective study included five consecutive patients treated with anti-proliferative drug-eluting stents. The patients' demographics, indications for treatment, procedural technique, and clinical and radiographic follow-up are presented along with a review of the literature. Results No peri-procedural complications occurred. One patient had a transient ischemic attack (TIA) during the follow-up period. No patients had hemodynamically significant (>50%) in-stent stenosis at follow-up. Among the 287 cases reported in the literature, there were two strokes (.7%), four TIAs (1.4%), and no procedurally related deaths. Among patients undergoing angiographic follow-up, 26% were found to have >50% in-stent stenosis. Conclusions Anti-proliferative drug-eluting stents hold promise for reducing in-stent stenosis at the vertebral artery origin.

AB - Background Vertebral artery origin stenosis is a known cause of stroke that is treatable with angioplasty and stenting. Previous studies have demonstrated that this technique is safe but is limited by high rates of in-stent stenosis. Anti-proliferative drug-eluting stents are an alternative for reducing in-stent stenosis at the vertebral artery origin. Methods This retrospective study included five consecutive patients treated with anti-proliferative drug-eluting stents. The patients' demographics, indications for treatment, procedural technique, and clinical and radiographic follow-up are presented along with a review of the literature. Results No peri-procedural complications occurred. One patient had a transient ischemic attack (TIA) during the follow-up period. No patients had hemodynamically significant (>50%) in-stent stenosis at follow-up. Among the 287 cases reported in the literature, there were two strokes (.7%), four TIAs (1.4%), and no procedurally related deaths. Among patients undergoing angiographic follow-up, 26% were found to have >50% in-stent stenosis. Conclusions Anti-proliferative drug-eluting stents hold promise for reducing in-stent stenosis at the vertebral artery origin.

KW - Drug-eluting

KW - Stenosis

KW - Stent

KW - Stroke

KW - Vertebral artery origin

UR - http://www.scopus.com/inward/record.url?scp=77950619539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950619539&partnerID=8YFLogxK

U2 - 10.1111/j.1552-6569.2008.00330.x

DO - 10.1111/j.1552-6569.2008.00330.x

M3 - Article

VL - 20

SP - 175

EP - 179

JO - Journal of Neuroimaging

JF - Journal of Neuroimaging

SN - 1051-2284

IS - 2

ER -